Important negative changes in Elevance Health Inc (NYSE: ELV) fundamentals have recently occurred: significant quarterly sales deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and the consensus estimate for December, 2025 decreased significantly.
Important negative changes in Elevance Health Inc (NYSE: ELV) investment behavior have recently occurred: negative upside/downside volume developed.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
Elevance Health has a current Value Trend Rating of C (Low Neutral). This rating combines contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Elevance Health has a slightly positive Appreciation Score of 62 but a slightly negative Power Rating of 33, resulting in the Low Neutral Value Trend Rating.
Recent Price Action
Elevance Health Inc (NYSE: ELV) stock closed at $400.69 on 11/15/24 after a modest decline of -1.6%. Moreover, unusually high trading volume at 157% of normal accompanied the decline. The stock has declined -6.7% during the last week and has been weak relative to the market over the last nine months.
Be the first to comment